Convulsant and anticonvulsant effects of bupropion in mice

European Journal of Pharmacology

Volumn 499, Issue 1-2, 2004, Pages 117-120

  Tutka, Piotr ^a   Barczynski, Bartlomiej ^a   Wielosz, Marian ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antidepressant drug; Bupropion; Epilepsy; Seizure; Smoking cessation

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; KAINIC ACID; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; ELECTRIC SHOCK; EPILEPSY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOKING CESSATION;

ANIMALS; ANTICONVULSANTS; BUPROPION; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; KAINIC ACID; MALE; MICE; PENTYLENETETRAZOLE; SEIZURES; SURVIVAL RATE;

EID: 19344378834     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.105     Document Type: Article

References (16)

1. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report JAMA 283 2000 3244 3254
2. M.G. Belson, and T.R. Kelley Bupropion exposures: clinical manifestations and medical outcome J. Emerg. Med. 23 2002 223 230
3. Y. Ben-Ari Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal epilepsy Neuroscience 14 1985 375 403
4. J. Davidson Seizures and bupropion: a review J. Clin. Psychiatry 50 1989 256 261
5. J.W. Dailey, and D.K. Naritoku Antidepressants and seizures: clinical anecdotes overshadow neuroscience Biochem. Pharmacol. 52 1996 1323 1329
6. J.A. Johnston, C.G. Lineberry, J.A. Ascher, J. Davidson, M.A. Khayrallah, J.P. Feighner, and P. Stark A 102 center prospective study of seizure in association with bupropion J. Clin. Psychiatry 52 1991 450 456
7. S.C. Lange, R.M. Julien, and G.W. Fowler Biphasic effects of imipramine in experimental models of epilepsy Epilepsia 17 1976 183 195
8. J.T. Litchfield, and F. Wilcoxon A simplified method of evaluating dose-effect experiments J. Pharmacol. Exp. Ther. 96 1949 99 113
9. W. Löscher, and D. Schmidt Which animal model should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations Epilepsy Res. 2 1988 145 181
10. A.W. Peck, W.C. Stern, and C. Watkinson Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion J. Clin. Psychiatry 44 1983 197 201
11. G.R. Pesola, and J. Avasarala Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department J. Emerg. Med. 22 2002 235 239
12. S. Prendiville, and K. Gale Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats Epilepsia 34 1993 381 384
13. J.E. Slemmer, B.R. Martin, and M.I. Damaj Bupropion is a nicotinic antagonist J. Pharmacol. Exp. Ther. 295 2000 321 327
14. G. Sperk Kainic acid seizures in the rat Prog. Neurobiol. 42 1994 1 32
15. E.A. Swinyard, W.C. Brown, and L.S. Goodman Comparative assays of antiepileptic drugs in mice and rats J. Pharmacol. Exp. Ther. 106 1952 319 330
16. J. Van Wyck Fleet, P.J. Manberg, L.L. Miller, N. Harto-Truax, T. Sato, R.J. Fleck, W.C. Stern, and A.E. Cato Overview of clinically significant adverse reactions to bupropion J. Clin. Psychiatry 44 1983 191 196